Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”

Author:

Kumar Manoj1,Nagpal Ravinder2,Kumar Rajesh1,Hemalatha R.1ORCID,Verma Vinod3,Kumar Ashok4,Chakraborty Chaitali5,Singh Birbal6,Marotta Francesco7,Jain Shalini8,Yadav Hariom8ORCID

Affiliation:

1. Department of Microbiology & Immunology, National Institute of Nutrition, Hyderabad, India

2. Department of Biotechnology, JMIT Institute of Technology, Radaur, Haryana, India

3. Research and Development Unit, National Heart Centre, Singapore

4. Department of Zoology, M.L.K. Post-Graduate College, Balrampur, India

5. Department of Biotechnology, ITS Paramedical College, Ghaziabad, India

6. Indian Veterinary Research Institute, Regional Station, Palampur, India

7. Hepato-Gastroenterology Unit, S. Giuseppe Hospital, Vittore, Milano, Italy

8. National Institute of Diabetes and Digestive and Kidney Diseases, NIH, MD, USA

Abstract

Publisher

Hindawi Limited

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference5 articles.

1. Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases

2. Bile Salt Hydrolase Activity in Probiotics

3. Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings

4. Probiotics as complementary therapy for hypercholesterolemia;M. R. Sudha;Biology and Medicine,2009

5. Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases;Unregistered Submission

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3